US FDA places clinical hold on Intellia’s gene therapy trials; shares fall EP News Bureau Oct 30, 2025 The hold follows a serious safety event involving liver-related complications in a participant receiving the investigational…
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData EP News Bureau Mar 13, 2021 Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences Usha Sharma Jan 7, 2015 To explore making medicines and drug discovery tools with CRISPR genome editing technology
